Literature DB >> 19489343

Chantix-induced mental status changes in a young healthy female.

Eric C Kutscher1, Matthew Stanley, Karl Oehlke.   

Abstract

A 24-year-old Caucasian female was voluntarily admitted to an inpatient psyciatric unit after starting varenicline (Chantix). She reported feelings of paranoia, anxiety and suicidal ideation. She had no known history of psychiatric illness and was on no other medications prior to starting varenicline. This was her first attempt at smoking cessation, and she decided to use varenicline at the recommendation of her primary care provider and the South Dakota QuitLine program. We report this case to inform health care providers that the potential for psychiatric effects is possible, even in those individuals who do not have a history of psychiatric illnesses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19489343

Source DB:  PubMed          Journal:  S D Med        ISSN: 0038-3317


  6 in total

1.  Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis.

Authors:  Serena Tonstad; Simon Davies; Martina Flammer; Cristina Russ; John Hughes
Journal:  Drug Saf       Date:  2010-04-01       Impact factor: 5.606

2.  Smoking cessation after brain damage does not lead to increased depression: implications for understanding the psychiatric complications of varenicline.

Authors:  Daniel Tranel; Ashton McNutt; Antoine Bechara
Journal:  Cogn Behav Neurol       Date:  2012-03       Impact factor: 1.600

Review 3.  Varenicline for tobacco dependence: panacea or plight?

Authors:  Jill M Williams; Michael B Steinberg; Marc L Steinberg; Kunal K Gandhi; Rajiv Ulpe; Jonathan Foulds
Journal:  Expert Opin Pharmacother       Date:  2011-06-06       Impact factor: 3.889

4.  A Review of Varenicline's Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia.

Authors:  Mahtab Karkhane Yousefi; Timothy D Folsom; S Hossein Fatemi
Journal:  J Addict Res Ther       Date:  2011-12-20

5.  Preclinical Pharmacology, Efficacy and Safety of Varenicline in Smoking Cessation and Clinical Utility in High Risk Patients.

Authors:  Zheng-Xiong Xi
Journal:  Drug Healthc Patient Saf       Date:  2010-04-01

Review 6.  Clinical utility of varenicline for smokers with medical and psychiatric comorbidity.

Authors:  Jon O Ebbert; Kirk D Wyatt; Ali Zirakzadeh; Michael V Burke; Jt Hays
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-11-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.